Dr. Pankit Vachhani
Claim this profileUniversity of Alabama at Birmingham
Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
15 reported clinical trials
23 drugs studied
Area of expertise
1Acute Myelogenous Leukemia
FLT3 positive
CBF positive
2Acute Myeloid Leukemia
FLT3 positive
CBF positive
Affiliated Hospitals
Clinical Trials Pankit Vachhani is currently running
BLU-263
for Systemic Mastocytosis
This trial tests BLU-263 combined with the best possible care for patients with specific conditions whose symptoms are not well-controlled. The medication aims to reduce symptoms by blocking overactive cells.
Recruiting0 awards Phase 2 & 312 criteria
Tuspetinib
for Acute Myeloid Leukemia
The main purpose of this study is to identify a safe and potentially effective dose of tuspetinib to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic syndromes with increased blasts grade 2 (MDS-IB2), or chronic myelomonocytic leukemia (CMML) that is relapsed or refractory after at least one line of prior therapy, or in study participants with newly diagnosed AML. Tuspetinib will be administered as a single agent or in combination with other drugs (venetoclax or venetoclax plus azacitidine), as specified for each part of the study.
Recruiting1 award Phase 1 & 222 criteria
More about Pankit Vachhani
Clinical Trial Related4 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Pankit Vachhani has experience with
- Placebo
- MT-401
- NTX-301
- ZN-c3
- ZN-d5
- TAS1553
Breakdown of trials Pankit Vachhani has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pankit Vachhani specialize in?
Pankit Vachhani focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved FLT3 positive patients, or patients who are CBF positive.
Is Pankit Vachhani currently recruiting for clinical trials?
Yes, Pankit Vachhani is currently recruiting for 3 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Pankit Vachhani has studied deeply?
Yes, Pankit Vachhani has studied treatments such as Placebo, MT-401, NTX-301.
What is the best way to schedule an appointment with Pankit Vachhani?
Apply for one of the trials that Pankit Vachhani is conducting.
What is the office address of Pankit Vachhani?
The office of Pankit Vachhani is located at: University of Alabama at Birmingham, Birmingham, Alabama 35249 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.